Home » Topics » BioWorld Science

BioWorld Science
RSS

For mutations, "synonymous" is not a synonym for silent, study finds

June 9, 2022

FDA clears IND application for SBT-115301 for autoimmune disease

June 9, 2022

MetasTx advances MTX-101 for prostate cancer and metastasis prevention

June 9, 2022

China's NMPA approves IND for B7H4x4-1BB bispecific antibody HBM-7008

June 9, 2022

OnCusp licenses ex-China rights to Multitude's CDH6 antibody-drug conjugate

June 9, 2022

Qualigen Therapeutics initiates IND-enabling studies for QN-302

June 9, 2022

FDA clears Passage Bio's IND for PBML-04 for metachromatic leukodystrophy

June 9, 2022

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

June 9, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Novel polyphenol derivative as potent DYRK1A inhibitor for the treatment of MS

June 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...